MARKET

HTGM

HTGM

HTG Molecular
NASDAQ

Real-time Quotes | Nasdaq Last Sale

5.81
-0.07
-1.19%
Closed 16:00 09/17 EDT
OPEN
5.93
PREV CLOSE
5.88
HIGH
6.02
LOW
5.71
VOLUME
38.65K
TURNOVER
--
52 WEEK HIGH
7.95
52 WEEK LOW
3.500
MARKET CAP
43.07M
P/E (TTM)
-1.8303
1D
5D
1M
3M
1Y
5Y
HTG Molecular Diagnostics to Present at H.C. Wainwright's 23rd Annual Global Investment Conference
HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that company management will participate in H.C. Wainwright's 23rd Annual Global Investment Conference, being held ...
GlobeNewswire · 09/08 20:10
Samjo Capital LLC Buys GTY Technology Holdings Inc, Recro Pharma Inc, Thryv Holdings Inc, Sells ...
GuruFocus News · 08/16 07:55
HTG Molecular Diagnostics Reports Second Quarter 2021 Results
HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today reported its financial results for the quarter ended June 30, 2021.
GlobeNewswire · 08/12 20:05
-- Earnings Flash (HTGM) HTG MOLECULAR DIAGNOSTICS Posts Q2 Revenue $2.1M
MT Newswires · 08/12 16:19
Earnings Scheduled For August 12, 2021
  Companies Reporting Before The Bell • Anavex Life Sciences (NASDAQ:AVXL) is estimated to report earnings for its third quarter.
Benzinga · 08/12 08:14
HTG’s New HTG Transcriptome Panel Launched with Commercial Availability in the U.S. and Europe
HTG Transcriptome Panel designed to measure approximately 20,000 mRNA targets using the HTG EdgeSeq technology Intended to serve as one of the technological cornerstones for the recently announced HTG Therapeutics Business Unit A third white paper highligh...
GlobeNewswire · 08/05 12:00
HTG Molecular Diagnostics to Announce Second Quarter 2021 Financial Results and Host Conference Call on Thursday, August 12
HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM), a life science company whose mission is to advance precision medicine, today announced that it will report its financial results for the second quarter ended June 30, 2021 after the market close on Thursday, ...
GlobeNewswire · 08/03 12:00
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers
Benzinga · 07/28 20:32
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of HTGM. Analyze the recent business situations of HTG Molecular through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average HTGM stock price target is 9.75 with a high estimate of 15.00 and a low estimate of 5.00.
EPS
Institutional Holdings
Institutions: 60
Institutional Holdings: 8.64M
% Owned: 116.63%
Shares Outstanding: 7.41M
TypeInstitutionsShares
Increased
10
805.51K
New
4
603.58K
Decreased
4
103.49K
Sold Out
3
29.70K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+1.54%
Healthcare Equipment & Supplies
+0.65%
Key Executives
Non-Executive Chairman/Independent Director
Ann Hanham
President/Chief Executive Officer/Director
John Lubniewski
Chief Financial Officer/Senior Vice President/Treasurer/Secretary
Shaun Mcmeans
Senior Vice President
Byron Lawson
Independent Director
Harry George
Independent Director
Michelle Griffin
Independent Director
Donnie Hardison
Independent Director
James Lafrance
Independent Director
Lee McCracken
No Data
About HTGM
HTG Molecular Diagnostics, Inc. is a commercial-stage company that develops and markets a technology platform to facilitate the routine use of complex molecular profiling. The Company's HTG Edge and HTG EdgeSeq platforms, consisting of instrumentation, consumables and software analytics, are used in sample profiling applications, including tumor profiling, molecular diagnostic testing and biomarker development. The Company's HTG Edge and HTG EdgeSeq platforms automate the molecular profiling of genes and gene activity using its nuclease protection chemistry on a range of biological samples. The Company's HTG EdgeSeq chemistry, together with its HTG Edge or HTG EdgeSeq instrumentation and software, automates and adapts its nuclease protection chemistry to enable analysis using next generation sequencing (NGS) instrumentation. The HTG EdgeSeq system utilizes substantially the same sample preparation reagents as its original chemistry, but allows for read out on an NGS instrument.

Webull offers kinds of HTG Molecular Diagnostics Inc stock information, including NASDAQ:HTGM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HTGM stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading HTGM stock methods without spending real money on the virtual paper trading platform.